Neuroprotective activities of bacopa, lycopene, astaxanthin,  and vitamin B12 combination on oxidative stress‐dependent neuronal death. Issue 12 (25th May 2020)

• Record Type: Journal Article
• Authors: Castelli, Vanessa; Melani, Francesco; Ferri, Claudio; d'Angelo, Michele; Catanesi, Mariano; Grassi, Davide; Benedetti, Elisabetta; Giordano, Antonio; Cimini, Annamaria; Desideri, Giovambattista
• Is Part Of: Journal of cellular biochemistry. Volume 121:Issue 12(2020)
• Page Start: 4862
• Page End: 4869
• Publication Date: 2020-05-25
• Subjects: antioxidants -- astaxanthin -- bacopa -- brain decline -- lycopene -- neuroprotection -- nutraceutical -- oxidative stress; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.29722
• Languages: English
• ISSNs: 0730-2312

Abstract

Abstract: Oxidative stress is considered the common effector of the cascade of degenerative events in many neurological conditions. Thus, in this paper we tested different nutraceuticals in H2 O2 in vitro model to understand if could represent an adjuvant treatment for neurological diseases. In this study, nutraceuticals bacopa, lycopene, astaxanthin, and vitamin B12 were used alone or in combination in human neuronal differentiated SH‐SY5Y cells upon hydrogen peroxide‐induced injury and neuroprotective, neuronal death pathways were analyzed. The nutraceuticals analyzed were able to protect H2 O2 cytotoxic effects, through increasing cell viability and proteins involved in neuroprotection pathways and restoring proteins involved in cell death pathways. On this basis, it is possible to propose the use of these compounds as dietary supplement for the prevention or as adjuvant to the only symptomatic treatments so far available for neurodegenerative diseases. Abstract : The nutraceuticals analyzed were able to protect H2 O2 cytotoxic effects. It is possible to propose the use of these compounds as a dietary supplement for the prevention of neuronal aging. It is possible to propose the use of these compounds as a dietary supplement for the prevention or as adjuvant to the only symptomatic treatments so far available for neurodegenerative diseases.